Collection of Transplant Stem Cells for Plasma Cell Myeloma

NCT01547806 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

49

Enrollment

NIH

Sponsor class

Conditions

Plasma Cell Myeloma
Multiple Myeloma

Interventions

DRUG: Filgrastim
DRUG: Plerixafor
PROCEDURE: Apheresis

Sponsor

National Cancer Institute (NCI)